Inhibition of Cbl-b restores effector functions of human intratumoral NK cells
Background T cell-based immunotherapies including immune checkpoint blockade and chimeric antigen receptor T cells can induce durable responses in patients with cancer.However, clinical efficacy is limited due to the ability of cancer cells to evade immune surveillance.While T Plates cells have been the primary focus of immunotherapy, recent resear